Evaluation of drugs for the treatment of gastroesophageal reflux disease (GORD)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/342691/09
Published14/03/2011
Effective from01/10/2011
KeywordsGastro-oesophageal reflux disease (GORD), reflux oesophagitis, non-erosive reflux disease (NERD)
DescriptionThis document addresses the European regulatory position on the development of products for the treatment of gastro-oesophageal reflux disease in adults and children.


Document history

First version 

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/10/2011–present


Published: 14/03/2011


Published: 08/01/2010


Published: 19/02/2009


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more